[go: up one dir, main page]

AR042498A1 - Procedimiento de estabilizacion quimica de un retinoide solubilizado y composicion obtenida de acuerdo con el procedimiento que comprende al menos un retinoide en forma salificada - Google Patents

Procedimiento de estabilizacion quimica de un retinoide solubilizado y composicion obtenida de acuerdo con el procedimiento que comprende al menos un retinoide en forma salificada

Info

Publication number
AR042498A1
AR042498A1 ARP030104669A ARP030104669A AR042498A1 AR 042498 A1 AR042498 A1 AR 042498A1 AR P030104669 A ARP030104669 A AR P030104669A AR P030104669 A ARP030104669 A AR P030104669A AR 042498 A1 AR042498 A1 AR 042498A1
Authority
AR
Argentina
Prior art keywords
retinoid
procedure
solubilized
chemical stabilization
obtained according
Prior art date
Application number
ARP030104669A
Other languages
English (en)
Spanish (es)
Inventor
Laurent Fredon
Sandrine Orsoni
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of AR042498A1 publication Critical patent/AR042498A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
ARP030104669A 2002-12-17 2003-12-17 Procedimiento de estabilizacion quimica de un retinoide solubilizado y composicion obtenida de acuerdo con el procedimiento que comprende al menos un retinoide en forma salificada AR042498A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0216017A FR2848451B1 (fr) 2002-12-17 2002-12-17 Procede de stabilisation chimique d'un retinoide solubilise et composition aqueuse obtenue selon le procede comprenant au moins un retinoide sous forme salifiee

Publications (1)

Publication Number Publication Date
AR042498A1 true AR042498A1 (es) 2005-06-22

Family

ID=32338901

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104669A AR042498A1 (es) 2002-12-17 2003-12-17 Procedimiento de estabilizacion quimica de un retinoide solubilizado y composicion obtenida de acuerdo con el procedimiento que comprende al menos un retinoide en forma salificada

Country Status (4)

Country Link
CN (1) CN1728983A (fr)
AR (1) AR042498A1 (fr)
FR (1) FR2848451B1 (fr)
ZA (1) ZA200505124B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2991176B1 (fr) * 2012-06-01 2014-12-19 Galderma Res & Dev Compositions topiques, contenant un retinoide solubilise, de type gel hydroglycolique
US9244054B2 (en) * 2012-07-10 2016-01-26 GM Global Technology Operations LLC Systems and methods for determining a state of deterioration of engine oil using multiple preselected oil properties

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601670B1 (fr) * 1986-07-17 1988-10-07 Cird Nouveaux derives bicycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
FR2647015B1 (fr) * 1989-05-17 1994-05-06 Cird Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique
ZA954599B (en) * 1994-06-07 1996-01-26 Allergan Inc Stable gel formulation for topical treatment of skin conditions
FR2731706B1 (fr) * 1995-03-14 1997-04-11 Cird Galderma Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
JP4061015B2 (ja) * 2000-10-30 2008-03-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 レチノイン酸レセプターアゴニスト作用を有する薬剤含有組成物

Also Published As

Publication number Publication date
CN1728983A (zh) 2006-02-01
FR2848451A1 (fr) 2004-06-18
ZA200505124B (en) 2007-03-28
FR2848451B1 (fr) 2007-01-12

Similar Documents

Publication Publication Date Title
AR064842A1 (es) Pirrolidin-2-onas, y su uso en la preparacion de inhibidores de nep
ES2545102T3 (es) Procedimiento para producir compuestos de lactamida, nuevos compuestos de lactamida y formulaciones que contienen compuestos de lactamida
AR032497A1 (es) Limpiador antimicrobiano acido para superficies duras
AR048017A1 (es) Composicion y metodo para aumentar la biodisponibilidad
JP2010531892A5 (fr)
NO20054465L (no) Topiske L-karnitinblandinger
BRPI0418245B8 (pt) composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes
WO2014131191A1 (fr) Composition contenant de l'honokiol et/ou du magnoliol et utilisations associées
EA200600528A1 (ru) Способ получения водорастворимых дитерпенов и их применение
JP2019535766A (ja) 抗菌ペプチド刺激性洗浄組成物
US20080146529A1 (en) Skin peeling composition and method
JP3510591B2 (ja) ポリエトキシル化レチンアミド誘導体およびその製造方法
MX2008002177A (es) Formulacion de argatroban.
AR042498A1 (es) Procedimiento de estabilizacion quimica de un retinoide solubilizado y composicion obtenida de acuerdo con el procedimiento que comprende al menos un retinoide en forma salificada
WO2005025503A3 (fr) Composition et methode de traitement pour affections urogenitales
RU2009128328A (ru) Косметическое средство
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
CY1107765T1 (el) Μεθοδος για τη δημιουργια μιας συνθεσης, ενα προϊον απο μια τετοια μεθοδο, και η χρηση αυτου στην αφαιρεση ή τη διαλυση ενος μολυσματος απο ενα περιβαλλον
BR0312179A (pt) Processo para preparação de derivado de epik5-n-o-supersulfato, composição farmacêutica e composição cosmética contendo o mesmo e seu uso
MXPA06013179A (es) Composicion anti-acne para el cuidado de la piel y articulo para el cuidado de la piel.
ATE266421T1 (de) Antifungizide zusammensetzung von ketoconazole zum auftragen
JP2008539227A (ja) ヒドロキサム酸誘導体及びその製造方法
DK1716845T3 (da) Formulering til dermal anvendelse
ES2193398T3 (es) Esteres eritro-3-amino-2-hidroxibutiricos opticamente activos y procedimiento para preparar dichos esteres.
TR200202439T2 (tr) Sodyum hidrojen değiştirici tip 1 önleyici (NHE-1)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal